(0.86%) 5 248.49 points
(1.22%) 39 760 points
(0.51%) 16 400 points
(1.25%) $82.37
(1.05%) $1.736
(0.71%) $2 228.50
(-0.19%) $24.71
(0.99%) $918.75
(0.19%) $0.925
(0.56%) $10.83
(-0.04%) $0.791
(0.16%) $92.59
Live Chart Being Loaded With Signals
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally...
Stats | |
---|---|
Today's Volume | 50 521.00 |
Average Volume | 1.62M |
Market Cap | 164.30M |
EPS | $0 ( 2024-03-04 ) |
Next earnings date | ( $-0.200 ) 2024-05-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.620 |
ATR14 | $0.00200 (0.22%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-05 | Deep Track Capital, Lp | Buy | 0 | Common Stock |
2024-02-20 | Zalevsky Jonathan | Sell | 9 014 | Common Stock |
2024-02-20 | Wilson Mark Andrew | Sell | 7 606 | Common Stock |
2024-02-20 | Robin Howard W | Sell | 20 033 | Common Stock |
2023-12-13 | Zalevsky Jonathan | Buy | 250 000 | Stock Option |
INSIDER POWER |
---|
84.81 |
Last 97 transactions |
Buy: 6 976 063 | Sell: 637 451 |
Volume Correlation
Nektar Therapeutics Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Nektar Therapeutics Correlation - Currency/Commodity
Nektar Therapeutics Financials
Annual | 2023 |
Revenue: | $90.12M |
Gross Profit: | $53.48M (59.34 %) |
EPS: | $-1.450 |
Q4 | 2023 |
Revenue: | $23.89M |
Gross Profit: | $16.60M (69.51 %) |
EPS: | $-0.220 |
Q3 | 2023 |
Revenue: | $24.14M |
Gross Profit: | $11.71M (48.51 %) |
EPS: | $-0.240 |
Q2 | 2023 |
Revenue: | $20.50M |
Gross Profit: | $13.51M (65.88 %) |
EPS: | $-0.270 |
Financial Reports:
No articles found.
Nektar Therapeutics
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, renal cell carcinoma, muscle-invasive bladder cancer, squamous cell carcinoma of the head and neck, and adjuvant melanoma; phase 2 clinical trial for the treatment of renal cell carcinoma, non-small cell lung cancer, and urothelial cancer; phase 1/2A clinical trial to treat squamous cell carcinoma of the head and neck; phase 1/2 clinical trial for the treatment of solid tumors; and phase 1B clinical trial to treat COVID-19. It is also developing NKTR-358, a cytokine Treg stimulant that is in phase 2 clinical trial for the treatment of systemic lupus erythematosus and ulcerative colitis, as well as phase 1B clinical trial to treat atopic dermatitis and psoriasis; NKTR-255, an IL-15 receptor agonist, which is in phase 1/2 clinical trial for the treatment of non-Hodgkin's lymphoma and multiple myeloma, and head and neck cancer and colorectal cancer; and NKTR-262, a toll-like receptor agonist that is in phase 1/2 clinical trial to treat solid tumors, as well as various other drug candidates. The company has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma S.A.; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; Amgen Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; Baxalta Incorporated; Eli Lilly and Company; Merck KGaA; and SFJ Pharmaceuticals, Inc. Nektar Therapeutics was incorporated in 1990 and is headquartered in San Francisco, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators